Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2010
06/03/2010US20100136085 Compositions and methods for arthrodetic procedures
06/03/2010US20100136026 Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis
06/03/2010US20100136023 Therapeutic agents
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136007 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135980 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
06/03/2010US20100135967 Cultured cartilage/bone cells/tissue, method of generating same and uses thereof
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/02/2010EP2191849A1 Drug for suppressing pathogen occurring<i>in vivo</i>
06/02/2010EP2191835A1 Therapeutic and prophylactic agents for arthritis
06/02/2010EP2191833A1 Transdermally absorbable preparation
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2190852A1 Bicyclic sphingosine 1-phosphate analogs
06/02/2010EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent
06/02/2010EP1830881B1 Combining therapies targeting multiple toll-like receptors and use thereof
06/02/2010CN1946743B Hyaluronic acid/methotrexate compound
06/02/2010CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN1805942B Diphenylurea derivatives and their use as chloride channel blockers
06/02/2010CN101720319A Thiazolidine derivatives and methods for the preparation thereof
06/02/2010CN101717711A Five-step wind-dispelling wine and preparation method thereof
06/02/2010CN101717416A Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101716320A Externally applied medical composition for treating orthopedic diseases and preparation method thereof
06/02/2010CN101716317A Orally taken and externally applied traditional Chinese medicine composite for treating rheumatoid arthritis
06/02/2010CN101716313A Traditional Chinese medicine composition for treating injured and broken fingers
06/02/2010CN101716312A Six ingredients gout powder prescription
06/02/2010CN101716289A Traditional Chinese medicine preparation for treating ischemic diseases
06/02/2010CN101716287A Medicament for mainly treating rheumatism rheumatoid factor negative of gout and preparation method thereof
06/02/2010CN101716277A Method for determining active ingredients of rhizoma smilacis glabrae medicinal material
06/02/2010CN101716275A Chinese patent medicament for treating osteomyelitis and preparation method
06/02/2010CN101716267A Traditonal Chinese medicine capsule fortreating femoral head necrosis, bone tuberculosis, osteomyelitis and osteoma
06/02/2010CN101716266A Medicaments for treating fractures and preparation method thereof
06/02/2010CN101716265A Traditional Chinese medicine combination for treating lumer disc hyperosteogeny
06/02/2010CN101716227A Medicament for treating rheumatoid arthritis and preparation method thereof
06/02/2010CN101716217A Medical composition containing rhododendron anthopogonoide oil and application thereof
06/02/2010CN101716194A Multi-flavor chewable calcium tablets and production process thereof
06/02/2010CN101716141A Fleroxacin injection and preparation method thereof
06/02/2010CN101716132A Febuxostat enteric preparation
06/02/2010CN101715956A Multifunctional health juice with stable effective ingredients and processing method thereof
06/02/2010CN101204505B Oral Chinese traditional medicine composition for osteoporosis
06/02/2010CN101185718B Medicine for treating bone joint disease and its preparation method
06/02/2010CN101181538B Plaster for curing bone injury and preparation method thereof
06/02/2010CN101181459B Chinese medicine for curing arthralgia
06/02/2010CN101181458B Chinese medicine preparation for curing fracture
06/02/2010CN101181377B Bone-knitting capsule and producing method thereof
06/02/2010CN101168035B External-applied medicine for treating hyperosteogeny
06/02/2010CN101167999B Hot compress exergy and preparation method thereof
06/02/2010CN101156918B A medicine for treating gout and preparation method
06/02/2010CN101156904B A externally used traditional Chinese medicine preparation for treating osteoproliferation as well as its preparation method
06/02/2010CN101129956B Traditional Chinese medicine for treating rickets
06/02/2010CN101129711B Black plaster
06/02/2010CN101085304B Plaster mainly for curing cervical vertebra and lumbar vertebra disease
06/02/2010CN101054345B Novel bensophenone derivatives or salts thereof
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
06/01/2010US7727527 Anti-NGF antibodies for the therapeutic treatments
06/01/2010CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2400626C Estrogen receptor modulators
06/01/2010CA2388237C Treatment of osteoporosis
06/01/2010CA2366750C (e)-styryl sulfone anticancer agents
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
06/01/2010CA2288373C Human cerberus protein
05/2010
05/27/2010WO2010059858A1 Manassantin compounds and methods of making and using same
05/27/2010WO2010059610A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058824A1 Substance for regulating differentiation into mesenchymal cell, and use thereof
05/27/2010WO2010058679A1 Fracture repair promoter
05/27/2010WO2010057442A1 A optical isomer of benzene propanoic acid and its medicinal use
05/27/2010WO2010036638A3 Compounds for the treatment of inflammatory disorders
05/27/2010WO2010023463A3 Polymer blends
05/27/2010WO2010019549A3 Indoprofen derivatives for promoting bone growth
05/27/2010WO2010017102A3 Secreted modular calcium binding protein for intracellular modulation of bone morphogenetic protein signaling
05/27/2010US20100130621 Use of hydroxytyrosol as anti-aging agent
05/27/2010US20100130563 Inhibitors of plasma kallikrein
05/27/2010US20100130517 New 4,8-diphenyl-polyazanaphthalene derivatives
05/27/2010US20100130510 Compounds for inflammation and immune-related uses
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130490 Csf-1r inhibitors,compositions, and methods of use
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130411 Method for treating cartilage disorders
05/27/2010US20100129421 Composition for promoting bone regeneration and restoration
05/27/2010US20100129378 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
05/27/2010US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof
05/27/2010US20100129373 Vegf-specific human antibody
05/27/2010US20100129366 Thiazole inhibitors of cyclooxygenase
05/27/2010CA2744343A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010CA2743406A1 Fracture repair promoter
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189445A1 Five-membered heterocyclic compound
05/26/2010EP2189439A2 CaSR antagonist
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP2187901A2 Therapeutic use of neuropeptide ei and a acth 7-38 and compositions thereof
1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 820